{
  "DOI": "10.1186/s40246-024-00594-9",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-024-00594-9",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eSLCO1B1 plays an important role in mediating hepatic clearance of many different drugs including statins, angiotensin-converting enzyme inhibitors, chemotherapeutic agents and antibiotics. Several variants in \u003cjats:italic\u003eSLCO1B1\u003c/jats:italic\u003e have been shown to have a clinically significant impact, in relation to efficacy of these medications. This study provides a comprehensive overview of \u003cjats:italic\u003eSLCO1B1\u003c/jats:italic\u003e variation in Saudi individuals, one of the largest Arab populations in the Middle East.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eThe dataset of 11,889 (9,961 exomes and 1,928 pharmacogenetic gene panel) Saudi nationals, was used to determine the presence and frequencies of \u003cjats:italic\u003eSLCO1B1\u003c/jats:italic\u003e variants, as described by the Clinical Pharmacogenetic Implementation Consortium (CPIC).\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eWe identified 141 previously described SNPs, of which rs2306283 (50%) and rs4149056 (28%), were the most common. In addition, we observed six alleles [\u003cjats:italic\u003e*15\u003c/jats:italic\u003e (24.7%) followed by *20 (8.04%), *14 (5.86%), *5 (3.84%), *31 (0.21%) and *9 (0.03%)] predicted to be clinically actionable. Allele diplotype to phenotype conversion revealed 41 OATP1B1 diplotypes. We estimated the burden of rare, and novel predicted deleterious variants, resulting from 17 such alterations.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eThe data we present, from one of the largest Arab cohorts studied to date, provides the most comprehensive overview of \u003cjats:italic\u003eSLCO1B1\u003c/jats:italic\u003e variants, and the subsequent OATP1B1 activity of this ethnic group, which thus far remains relatively underrepresented in available international genomic databases. We believe that the presented data provides a basis for further clinical investigations and the application of personalized statin drug therapy guidance in Arabs.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "594"
  ],
  "article-number": "30",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "12 October 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "29 February 2024"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "25 March 2024"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics statement",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The present study was performed according to the principles of the Declaration of Helsinki and the legal requirements of Saudi Arabia."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Goljan",
      "given": "Ewa",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Abouelhoda",
      "given": "Mohammed",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tahir",
      "given": "Asma",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "ElKalioby",
      "given": "Mohamed",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Meyer",
      "given": "Brian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Monies",
      "given": "Dorota",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2024,
        3,
        25
      ]
    ],
    "date-time": "2024-03-25T04:19:34Z",
    "timestamp": 1711340374000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        3,
        25
      ]
    ],
    "date-time": "2024-03-25T04:21:13Z",
    "timestamp": 1711340473000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        26
      ]
    ],
    "date-time": "2024-03-26T01:01:28Z",
    "timestamp": 1711414888348
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2024,
        3,
        25
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2024,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            3,
            25
          ]
        ],
        "date-time": "2024-03-25T00:00:00Z",
        "timestamp": 1711324800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            3,
            25
          ]
        ],
        "date-time": "2024-03-25T00:00:00Z",
        "timestamp": 1711324800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-024-00594-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-024-00594-9/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-024-00594-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2024,
        3,
        25
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2024,
        3,
        25
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/jps.22576",
      "author": "T Nakanishi",
      "doi-asserted-by": "publisher",
      "first-page": "3731",
      "issue": "9",
      "journal-title": "J Pharm Sci",
      "key": "594_CR1",
      "unstructured": "Nakanishi T, Tamai I. Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy. J Pharm Sci. 2011;100(9):3731–50.",
      "volume": "100",
      "year": "2011"
    },
    {
      "DOI": "10.1002/1520-6017(200011)89:11\u003c1371::AID-JPS1\u003e3.0.CO;2-D",
      "author": "I Tamai",
      "doi-asserted-by": "publisher",
      "first-page": "1371",
      "issue": "11",
      "journal-title": "J Pharm Sci",
      "key": "594_CR2",
      "unstructured": "Tamai I, Tsuji A. Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci. 2000;89(11):1371–88.",
      "volume": "89",
      "year": "2000"
    },
    {
      "DOI": "10.1248/bpb.b14-00767",
      "author": "K Maeda",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "issue": "2",
      "journal-title": "Biol Pharm Bull",
      "key": "594_CR3",
      "unstructured": "Maeda K. Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs. Biol Pharm Bull. 2015;38(2):155–68.",
      "volume": "38",
      "year": "2015"
    },
    {
      "DOI": "10.3390/ijms19030855",
      "doi-asserted-by": "crossref",
      "key": "594_CR4",
      "unstructured": "Alam K, Crowe A, Wang X, Zhang P, Ding K, Li L, Yue W. Regulation of Organic Anion transporting polypeptides (OATP) 1B1- and OATP1B3-Mediated transport: an updated review in the context of OATP-Mediated drug-drug interactions. Int J Mol Sci 2018, 19(3)."
    },
    {
      "DOI": "10.1038/nrd2423",
      "author": "RA Wilke",
      "doi-asserted-by": "publisher",
      "first-page": "904",
      "issue": "11",
      "journal-title": "Nat Rev Drug Discov",
      "key": "594_CR5",
      "unstructured": "Wilke RA, Lin DW, Roden DM, Watkins PB, Flockhart D, Zineh I, Giacomini KM, Krauss RM. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov. 2007;6(11):904–16.",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ahj.2007.06.034",
      "author": "SSC Group",
      "doi-asserted-by": "publisher",
      "first-page": "815",
      "issue": "5",
      "journal-title": "Am Heart J",
      "key": "594_CR6",
      "unstructured": "Group SSC, Bowman L, Armitage J, Bulbulia R, Parish S, Collins R. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors. Am Heart J. 2007;154(5):815–23. 823 e811-816.",
      "volume": "154",
      "year": "2007"
    },
    {
      "DOI": "10.1111/jcpt.12805",
      "author": "JCM Chan",
      "doi-asserted-by": "publisher",
      "first-page": "381",
      "issue": "3",
      "journal-title": "J Clin Pharm Ther",
      "key": "594_CR7",
      "unstructured": "Chan JCM, Ng MH, Wong RSM, Tomlinson B. A case of simvastatin-induced myopathy with SLCO1B1 genetic predisposition and co-ingestion of linagliptin and Stevia rebaudiana. J Clin Pharm Ther. 2019;44(3):381–3.",
      "volume": "44",
      "year": "2019"
    },
    {
      "DOI": "10.1253/circj.67.287",
      "author": "Y Matsuzawa",
      "doi-asserted-by": "publisher",
      "first-page": "287",
      "issue": "4",
      "journal-title": "Circ J",
      "key": "594_CR8",
      "unstructured": "Matsuzawa Y, Kita T, Mabuchi H, Matsuzaki M, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, et al. Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients. Circ J. 2003;67(4):287–94.",
      "volume": "67",
      "year": "2003"
    },
    {
      "DOI": "10.3390/genes10040261",
      "doi-asserted-by": "crossref",
      "key": "594_CR9",
      "unstructured": "Davila-Fajardo CL, Diaz-Villamarin X, Antunez-Rodriguez A, Fernandez-Gomez AE, Garcia-Navas P, Martinez-Gonzalez LJ, Davila-Fajardo JA, Barrera JC. Pharmacogenetics in the treatment of Cardiovascular diseases and its current progress regarding implementation in the clinical routine. Genes (Basel) 2019, 10(4)."
    },
    {
      "DOI": "10.1038/clpt.2014.125",
      "author": "LB Ramsey",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "issue": "4",
      "journal-title": "Clin Pharmacol Ther",
      "key": "594_CR10",
      "unstructured": "Ramsey LB, Johnson SG, Caudle KE, Haidar CE, Voora D, Wilke RA, Maxwell WD, McLeod HL, Krauss RM, Roden DM, et al. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. Clin Pharmacol Ther. 2014;96(4):423–8.",
      "volume": "96",
      "year": "2014"
    },
    {
      "DOI": "10.2133/dmpk.22.456",
      "author": "SR Kim",
      "doi-asserted-by": "publisher",
      "first-page": "456",
      "issue": "6",
      "journal-title": "Drug Metab Pharmacokinet",
      "key": "594_CR11",
      "unstructured": "Kim SR, Saito Y, Sai K, Kurose K, Maekawa K, Kaniwa N, Ozawa S, Kamatani N, Shirao K, Yamamoto N, et al. Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15. Drug Metab Pharmacokinet. 2007;22(6):456–61.",
      "volume": "22",
      "year": "2007"
    },
    {
      "DOI": "10.3389/fphar.2020.00728",
      "author": "C Na Nakorn",
      "doi-asserted-by": "publisher",
      "first-page": "728",
      "journal-title": "Front Pharmacol",
      "key": "594_CR12",
      "unstructured": "Na Nakorn C, Waisayarat J, Dejthevaporn C, Srisawasdi P, Wongwaisayawan S, Sukasem C. Genetic variations and frequencies of the two functional single nucleotide polymorphisms of SLCO1B1 in the Thai Population. Front Pharmacol. 2020;11:728.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1089/omi.2016.0119",
      "author": "E Aklillu",
      "doi-asserted-by": "publisher",
      "first-page": "538",
      "issue": "9",
      "journal-title": "OMICS",
      "key": "594_CR13",
      "unstructured": "Aklillu E, Habtewold A, Ngaimisi E, Yimer G, Mugusi S, Amogne W, Reuter T, Meid A, Hoffmann MM, Weiss J. SLCO1B1 gene variations among tanzanians, ethiopians, and europeans: relevance for African and Worldwide Precision Medicine. OMICS. 2016;20(9):538–45.",
      "volume": "20",
      "year": "2016"
    },
    {
      "DOI": "10.1124/pr.110.002857",
      "author": "M Niemi",
      "doi-asserted-by": "publisher",
      "first-page": "157",
      "issue": "1",
      "journal-title": "Pharmacol Rev",
      "key": "594_CR14",
      "unstructured": "Niemi M, Pasanen MK, Neuvonen PJ. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011;63(1):157–81.",
      "volume": "63",
      "year": "2011"
    },
    {
      "DOI": "10.1053/j.gastro.2006.02.034",
      "author": "RH Ho",
      "doi-asserted-by": "publisher",
      "first-page": "1793",
      "issue": "6",
      "journal-title": "Gastroenterology",
      "key": "594_CR15",
      "unstructured": "Ho RH, Tirona RG, Leake BF, Glaeser H, Lee W, Lemke CJ, Wang Y, Kim RB. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology. 2006;130(6):1793–806.",
      "volume": "130",
      "year": "2006"
    },
    {
      "DOI": "10.1056/NEJMoa0801936",
      "author": "SC Group",
      "doi-asserted-by": "publisher",
      "first-page": "789",
      "issue": "8",
      "journal-title": "N Engl J Med",
      "key": "594_CR16",
      "unstructured": "Group SC, Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R. SLCO1B1 variants and statin-induced myopathy–a genomewide study. N Engl J Med. 2008;359(8):789–99.",
      "volume": "359",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0140-6736(11)61125-2",
      "author": "G Collaborative",
      "doi-asserted-by": "publisher",
      "first-page": "2013",
      "issue": "9808",
      "journal-title": "Lancet",
      "key": "594_CR17",
      "unstructured": "Heart Protection Study, Collaborative G. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial. Lancet. 2011;378(9808):2013–20.",
      "volume": "378",
      "year": "2011"
    },
    {
      "DOI": "10.1038/clpt.2012.57",
      "author": "RA Wilke",
      "doi-asserted-by": "publisher",
      "first-page": "112",
      "issue": "1",
      "journal-title": "Clin Pharmacol Ther",
      "key": "594_CR18",
      "unstructured": "Wilke RA, Ramsey LB, Johnson SG, Maxwell WD, McLeod HL, Voora D, Krauss RM, Roden DM, Feng Q, Cooper-Dehoff RM, et al. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. Clin Pharmacol Ther. 2012;92(1):112–7.",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1002/cpt.2557",
      "doi-asserted-by": "crossref",
      "key": "594_CR19",
      "unstructured": "Cooper-DeHoff RM, Niemi M, Ramsey LB, Luzum JA, Tarkiainen EK, Straka RJ, Gong L, Tuteja S, Wilke RA, Wadelius M et al. The clinical pharmacogenetics implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and statin-Associated Musculoskeletal symptoms. Clin Pharmacol Ther 2022."
    },
    {
      "DOI": "10.1038/nature19057",
      "author": "M Lek",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "issue": "7616",
      "journal-title": "Nature",
      "key": "594_CR20",
      "unstructured": "Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91.",
      "volume": "536",
      "year": "2016"
    },
    {
      "DOI": "10.1101/gr.129668.111",
      "author": "LB Ramsey",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Genome Res",
      "key": "594_CR21",
      "unstructured": "Ramsey LB, Bruun GH, Yang W, Trevino LR, Vattathil S, Scheet P, Cheng C, Rosner GL, Giacomini KM, Fan Y, et al. Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Res. 2012;22(1):1–8.",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1038/s41525-022-00281-5",
      "author": "PV Jithesh",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "issue": "1",
      "journal-title": "NPJ Genom Med",
      "key": "594_CR22",
      "unstructured": "Jithesh PV, Abuhaliqa M, Syed N, Ahmed I, El Anbari M, Bastaki K, Sherif S, Umlai UK, Jan Z, Gandhi G, et al. A population study of clinically actionable genetic variation affecting drug response from the Middle East. NPJ Genom Med. 2022;7(1):10.",
      "volume": "7",
      "year": "2022"
    },
    {
      "DOI": "10.1371/journal.pgen.1009323",
      "author": "MHC Yu",
      "doi-asserted-by": "publisher",
      "first-page": "e1009323",
      "issue": "2",
      "journal-title": "PLoS Genet",
      "key": "594_CR23",
      "unstructured": "Yu MHC, Chan MCY, Chung CCY, Li AWT, Yip CYW, Mak CCY, Chau JFT, Lee M, Fung JLF, Tsang MHY, et al. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population. PLoS Genet. 2021;17(2):e1009323.",
      "volume": "17",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s40246-018-0157-3",
      "author": "M Ingelman-Sundberg",
      "doi-asserted-by": "publisher",
      "first-page": "26",
      "issue": "1",
      "journal-title": "Hum Genomics",
      "key": "594_CR24",
      "unstructured": "Ingelman-Sundberg M, Mkrtchian S, Zhou Y, Lauschke VM. Integrating rare genetic variants into pharmacogenetic drug response predictions. Hum Genomics. 2018;12(1):26.",
      "volume": "12",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s13059-015-0693-2",
      "author": "G Saudi Mendeliome",
      "doi-asserted-by": "publisher",
      "first-page": "134",
      "journal-title": "Genome Biol",
      "key": "594_CR25",
      "unstructured": "Saudi Mendeliome G. Comprehensive gene panels provide advantages over clinical exome sequencing for mendelian diseases. Genome Biol. 2015;16:134.",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1038/gim.2016.37",
      "author": "M Abouelhoda",
      "doi-asserted-by": "publisher",
      "first-page": "1244",
      "issue": "12",
      "journal-title": "Genet Med",
      "key": "594_CR26",
      "unstructured": "Abouelhoda M, Sobahy T, El-Kalioby M, Patel N, Shamseldin H, Monies D, Al-Tassan N, Ramzan K, Imtiaz F, Shaheen R, et al. Clinical genomics can facilitate countrywide estimation of autosomal recessive disease burden. Genet Med. 2016;18(12):1244–9.",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ajhg.2018.07.015",
      "author": "BL Browning",
      "doi-asserted-by": "publisher",
      "first-page": "338",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "594_CR27",
      "unstructured": "Browning BL, Zhou Y, Browning SR. A one-penny Imputed Genome from Next-Generation reference panels. Am J Hum Genet. 2018;103(3):338–48.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1086/521987",
      "author": "SR Browning",
      "doi-asserted-by": "publisher",
      "first-page": "1084",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "594_CR28",
      "unstructured": "Browning SR, Browning BL. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet. 2007;81(5):1084–97.",
      "volume": "81",
      "year": "2007"
    },
    {
      "DOI": "10.1093/nar/gkaa942",
      "author": "KL Howe",
      "doi-asserted-by": "publisher",
      "first-page": "D884",
      "issue": "D1",
      "journal-title": "Nucleic Acids Res",
      "key": "594_CR29",
      "unstructured": "Howe KL, Achuthan P, Allen J, Allen J, Alvarez-Jarreta J, Amode MR, Armean IM, Azov AG, Bennett R, Bhai J, et al. Ensembl 2021. Nucleic Acids Res. 2021;49(D1):D884–91.",
      "volume": "49",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41397-018-0044-2",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "115",
      "issue": "2",
      "journal-title": "Pharmacogenomics J",
      "key": "594_CR30",
      "unstructured": "Zhou Y, Mkrtchian S, Kumondai M, Hiratsuka M, Lauschke VM. An optimized prediction framework to assess the functional impact of pharmacogenetic variants. Pharmacogenomics J. 2019;19(2):115–26.",
      "volume": "19",
      "year": "2019"
    }
  ],
  "reference-count": 30,
  "references-count": 30,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-024-00594-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Large-scale next generation sequencing based analysis of SLCO1B1 pharmacogenetics variants in the Saudi population"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "18"
}